Mobilizing the world TO END CERVICAL CANCER


The knowledge and technology exist to eliminate cervical cancer with effective, low-cost tools, even in the poorest parts of the world. TogetHER is a global partnership focused on bold action and mobilizing the world to end cervical cancer.



TogetHER has joined a group of 20 organizations calling on the new administration to build on current commitments to eliminate cervical cancer through coordinated efforts to promote HPV vaccination, as well as cervical screening and treatment.

TogetHER and Cervical Cancer Action for Elimination have co-authored a blog post detailing COVID-19’s impact on cervical cancer prevention efforts around the world and spotlighting ways in which programs are innovating to keep women protected. This collaboration - hosted on the NCD Alliance's website - also highlights Cervical Cancer Awareness Month, taking place in January.

Despite the COVID-19 pandemic’s disruption, we were still fortunate to witness history in the making on November 17th, when the World Health Organization approved its Global Strategy to Accelerate the Elimination of Cervical Cancer as a Public Health Problem.
Read our thoughts on 2020 - both challenges and accomplishments!

The impact of COVID-19 on global cervical cancer prevention efforts has been wide-ranging, with unclear long-term ramifications. Our TogetHER Interview series provides an opportunity for key leaders in global cervical cancer control to discuss current challenges and provide perspective on where the field needs to go from here.

Read more from global leaders at Grounds for Health, Pathfinder International, Population Services International, PCI/Global Communities, PATHJhpiego, and Basic Health International.

And, get country-level perspectives from Pathfinder International (Ethiopia), Women 4 Cancer (Kenya), The Lily Project (Nicaragua), the Cervical Cancer Prevention and Training Centre in Catholic Hospital (Ghana), and Prof. Groesbeck Parham from the University of North Carolina/University of Zambia.